Association between glycosylated hemoglobin level and 16-year incidence of chronic kidney disease in type 1 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 3, 2007, Pages 203-206

  Shankar, A ^a   Klein, R ^b   Klein, B E K ^b   Moss, S E ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Chronic kidney disease; CKD; Epidemiology; ESRD; Glycemic control; Type 1 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ANAMNESIS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED STATES;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC;

EID: 34247399855     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-956170     Document Type: Article

References (30)

1. Klein R, Klein BE, Moss S, DeMets DL: Proteinuria in diabetes. Arch Intern Med 1988; 148: 181-186
2. Klein R, Klein BE, Linton KL, Moss SE: Microalbuminuria in a population-based study of diabetes. Arch Intern Med 1992; 152: 153-158
3. Klein R, Klein BE, Moss SE, Cruickshanks KJ: Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 1995; 44: 916-923
4. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-1255
5. Rossing P, Rossing K, Jacobsen P, Parving HH: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 1995; 44: 739-743
6. Orchard TJ, Dorman JS, Maser RE et al.: Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 1990; 13: 741-747
7. Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien D: Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 1989; 261: 1155-1160
8. Feldt-Rasmussen B, Mathiesen ER, Deckert T: Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986; 2: 1300-1304
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986
10. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-309
11. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int 1995; 47: 1703-1720
12. Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC: The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999; 22: 743-751
13. Ueda H, Ishimura E, Shoji T et al.: Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 2003; 26: 1530-1534
14. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH: Progression of diabetic nephropathy. Kidney Int 2001; 59: 702-709
15. Breyer JA, Bain RP, Evans JK et al.: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int 1996; 50: 1651-1658
16. Krolewski M, Eggers PW, Warram JH: Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996; 50: 2041-2046
17. Feest TG, Dunn EJ, Burton CJ: Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure? QJM 1999; 92: 275-282
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1):S1-266
19. Klein R, Klein BE, Moss SE, DeMets DL, Kaufman I, Voss PS: Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 1984; 119: 54-61
20. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-526
21. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL: Wisconsin epidemiologic study of diabetic retinopathy. XII. Relationship of C-peptide and diabetic retinopathy. Diabetes 1990; 39: 1445-1450
22. Moss SE, Klein R, Klein BE, Spennetta TL, Shrago ES: Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol 1988; 41: 645-649
23. Klein R, Moss S, Diabetes Control and Complications Trial Research Group: A comparison of the study populations in the diabetes control and complications trial and the Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 1995; 155: 745-754
24. The hypertension detection and follow-up program: hypertension detection and follow-up program cooperative group. Prev Med 1976: 5: 207-215
25. Poggio ED, Wang X, Greene T, Van LF, Hall PM: Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-466
26. Rigalleau V, Lasseur C, Raffaitin C et al.: Glucose control influences glomerular filtration rate and its prediction in diabetic subjects. Diabetes Care 2006; 29: 1491-1495
27. Alberti C, Metivier F, Landais P, Thervet E, Legendre C, Chevret S: Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol 2003; 56: 536-545
28. Hosmer DW, Lemeshow S: Applied logistic regression (pages 238-245), ISBN 0471615536. New York: Wiley, 1989
29. Coresh J, Astor BC, McQuillan G et al.: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920-929
30. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1):S33-S50